| Antimicrobial Preoperative Prophylaxis Guidelines |
|
Category
|
Procedure
|
Adult Dosage*
|
|
Abdominal
|
Gastroduodenal surgery in patients with hemorrhage, cancer, obstruction, or other high-risk features
|
Cefazolin 1–2 g IV preoperatively
or
Clindamycin 600 mg plus gentamicin 120 mg IV preoperatively
|
|
Gastric bypass
|
Cefazolin 1–2 g IV preoperatively
|
|
Percutaneous gastrostomy
|
Cefazolin 1–2 g IV preoperatively
|
|
Biliary tract (including ERCP) in patients who have acute symptoms, jaundice, or other high-risk features or who have had previous surgery
|
Cefazolin 1–2 g IV preoperatively
or
Gentamicin 80 mg IV preoperatively and q 8 h for 3 doses
|
|
Appendectomy (without perforation)
|
Cefoxitin, cefotetan, or cefmetazole 1–2 g IV preoperatively and q 6 h for 3 doses
or
Metronidazole 500 IV mg plus gentamicin 1.5 mg/kg IV preoperatively
|
|
Colorectal surgery, elective
|
Neomycin 1 g plus erythromycin base 1 g po at 1, 2, and 11 pm on the day before surgery ± parenteral drugs listed below for colorectal surgery
|
|
Colorectal surgery, emergency
|
Cefoxitin, cefotetan, or cefmetazole 2 g IV preoperatively and q 4 h for 3 doses
or
Metronidazole 500 mg IV plus gentamicin 1.7 mg/kg IV preoperatively and q 8 h for 3 doses
|
|
Cardiac
|
Median sternotomy, coronary artery bypass graft surgery, valve surgery, or pacemaker insertion
|
Cefazolin 2 g IV preoperatively and q 4–6 h intraoperatively
or
Cefuroxime 1.5 g IV preoperatively and q 4–6 h intraoperatively
or
Vancomycin 1 g IV preoperatively
|
|
Neurosurgical
|
Craniotomy, high-risk only (eg, reexplorations, microsurgery, entry into sinuses or nasopharynx)
|
Vancomycin 1g IV plus gentamicin 1.5 mg/kg IV preoperatively
or
Cefazolin 1 g IV preoperatively
|
|
CSF shunt placement—only in hospitals with high infection rates (15–20%)
|
Trimethoprim 160 mg IV plus sulfamethoxazole 800 mg IV preoperatively and q 12 h for 3 doses
or
Vancomycin 10 mg plus gentamicin 3 mg injected into a cerebral ventricle
|
|
Noncardiac thoracic
|
Pneumonectomy, lobectomy, other resections, or esophageal surgery
|
Cefazolin 1–2 g IV preoperatively and q 6 h for 24 h
or
Vancomycin 1 g IV preoperatively
|
|
Obstetric-gynecologic
|
Cesarean delivery, high-risk only (eg, premature rupture of membranes)
|
Cefazolin 1 g IV after clamping cord and q 6 h for 2 doses
|
|
Abortion, 2nd-trimester instillation
|
Cefazolin 1 g IV preoperatively and q 6 h for 2 doses
|
|
Abortion, 1st trimester in patients with a history of pelvic inflammatory disease, gonorrhea, or multiple partners
|
Penicillin G 1–2 million units IV preoperatively and 3 h later
or
Doxycycline 100 mg po before the procedure and 200 mg ½ h afterward
|
|
Hysterectomy, vaginal or abdominal
|
Cefazolin 1 g IV preoperatively and q 6 h for 2 doses
or
Doxycycline 200 mg IV preoperatively
|
|
Ophthalmic
|
Extraction of lens, with or without insertion of prosthesis
|
Gentamicin, tobramycin, or neomycin-gramicidin-polymyxin B drops over 2–24 h plus cefazolin 100 mg subconjunctivally at the end of the procedure
|
|
Orthopedic
|
Arthroplasty, including replacements
|
Cefazolin 1–2 g IV preoperatively and q 6 h for 3 doses
or
Vancomycin 1 g IV preoperatively
|
|
Open reduction of fractures
|
Cefazolin 1 g IV preoperatively and as a single dose postoperatively
|
|
Lower-extremity amputation (nonischemic)
|
Cefoxitin 2 g IV preoperatively and q 6 h for 4 doses
|
|
Otolaryngologic
|
Major head and neck surgery involving mucosa of the oral cavity or pharynx
|
Cefazolin 1–2 g IV preoperatively and q 8 h for 2 doses
or
Clindamycin 600–900 mg IV ± gentamicin 1.5 mg/kg IV preoperatively and q 8 h for 2 doses
|
|
Urologic
|
Prostatectomy if bacteriuria is present
|
Cefazolin 1 g IV preoperatively or another drug selected based on susceptibility tests
|
|
Penile prosthesis insertion
|
Cefazolin 1 g IV preoperatively
|
|
Vascular
|
Lower-extremity or abdominal arterial surgery or lower- extremity amputation for ischemia
|
Cefazolin 1–2 g IV preoperatively and q 6 h for 24 h
or
Vancomycin 1 g IV preoperatively and 12 h after the procedure
|
|
*Drugs, dosages, routes, and frequencies given represent recent expert recommendations. Cefazolin remains highly favored because of its spectrum of bactericidal activity, long half-life, low cost, and low toxicity. Alternatives are primarily for patients with β-lactam allergies.
|
|
± = with or without.
|
|
Adapted from Kernodle DS, Kaiser AB: Postoperative infections and antimicrobial prophylaxis. In Principles and Practice of Infectious Diseases, ed 5, edited by GL Mandell, JE Bennett, and R Dolin. New York, Churchill Livingstone, 2000, pp. 3186–3187 and from Antimicrobial prophylaxis in surgery. The Medical Letter 37:79–82, 1995.
|